Vascular Closure Devices Market by Type (Passive Approximators, Active Approximators, External Hemostatic Devices), Access (Femoral, Radial), Procedure (Interventional Cardiology, Interventional Radiology/Vascular Surgery) And by Region (North America, Europe, Asia Pacific, South America, Middle East and Africa), Global Trends and Forecast From 2022 To 2029

Published on: May 2022
From:USD $3499.00
Number Of Pages:150

Please Choose License Type

Single User

Team User

Corporate License

Request a Sample

INTERESTED IN THIS RESEARCH?

Contact our analysts for inquiries, samples, and expert insights.

Market Size	CAGR	Dominating Region
USD 1.5 billion	7.0%	North America

by Type	by Access	by Procedure
Passive Approximaters Active Approximaters External Homeostatic Devices	Radial Femoral	Interventional Cardiology Interventional Radiology/Vascular Surgery

4.8/5 - (21 votes)

Vascular Closure Devices Market Overview

The global vascular closure devices market is expected to grow at more than 7% CAGR from 2022 to 2029. It is expected to reach above USD 1.5 billion by 2029 from USD 0.8 billion in 2020.

The expansion observed in this market can be attributed to several factors, including the substantial number of approvals granted for vascular closure devices, the prevalent incidence of cardiovascular diseases, the escalating prevalence of obesity, the growing emphasis of market entities on large-bore vascular closure devices, the burgeoning geriatric demographic, the favorable reimbursement landscape for interventional radiology procedures, and the heightened focus on efficacious blood loss management during surgical interventions. Additionally, emerging markets present lucrative growth prospects for market participants, alongside the proliferation of hospitals and surgical centers, which collectively offer robust growth opportunities.

The Vascular Closure Devices (VCDs) market encompasses an array of medical devices engineered to achieve hemostasis subsequent to minimally invasive vascular procedures, notably cardiac catheterization and peripheral vascular interventions. These devices are instrumental in sealing puncture sites within arteries or veins, thereby mitigating the risk of post-procedural bleeding complications. VCDs present distinct advantages over conventional manual compression techniques, including expedited hemostasis, reduced time to ambulation, diminished patient discomfort, and abbreviated hospital stays. Noteworthy types of vascular closure devices encompass collagen plugs, suture-mediated devices, clip-based systems, and hemostatic patches, each tailored with specific mechanisms of action to cater to diverse anatomical sites and procedural requisites.

ATTRIBUTE	DETAILS
Study period	2020-2029
Base year	2021
Estimated year	2022
Forecasted year	2022-2029
Historical period	2018-2020
Unit	Value (USD Billion)
Segmentation	By Type, By Access, By Procedure
By Type	Passive Approximators Active Approximators External Homeostatic Devices
By Access	Radial Femoral
By Procedure	Interventional Cardiology Interventional Radiology/Vascular Surgery
By Region	North America Europe Asia Pacific South America Middle East And Africa

The global regulatory landscape governing vascular closure devices is characterized by a multifaceted framework comprising standards, guidelines, and regulations promulgated by regulatory authorities across different nations and regions. Entities such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the Japan Pharmaceuticals and Medical Devices Agency (PMDA) delineate requirements pertaining to the safety, efficacy, and quality of VCDs via pre-market approval processes, post-market surveillance mechanisms, and routine evaluations.

Vascular Closure Devices Market | Exactitude Consultancy

Vascular Closure Devices Market Segment Analysis

In terms of value, oligomers account for a sizable portion of the composition type.

The sector of passive approximators led the Vascular closure devices market.

The vascular closure devices market is divided into three types: passive approximators, active approximators, and external hemostatic devices. The market for vascular closure devices is dominated by passive approximators. The growing number of vascular closure device approvals, as well as the numerous benefits connected with these devices, such as ease of use and a lower complication rate in patients, can be attributable to the substantial proportion of this market.

During the projected period, the interventional radiology segment is expected to increase the most.The vascular closure devices market is divided into two segments based on procedure: interventional cardiology procedures and interventional radiology/vascular surgery. The interventional cardiology segment accounts for the lion’s share of the vascular closure devices market. Because of developments in angioplasty and cardiac stenting, as well as the increased frequency of cardiac illnesses internationally, the major share is attributable to the diagnosis and treatment of multiple cardiovascular disorders.

The primary customers of vascular closure devices are acute care centers, clinics, and hospitals. Acute care facilities are the market’s most important end consumers. There has also been an increase in the number of cases of cardiovascular disorders that require immediate treatment, which has raised awareness of the use of VCDs in acute care treatment. Furthermore, the use of imaging technologies, such as echocardiography, in acute treatment for CVD drives market expansion.

In addition to disease prevalence, technological advancements in vascular closure devices will drive industry revenue in the next few years. The advancement of vascular closure devices enabled minimal intrusions, great patient outcomes, early ambulation, a short hospital stay, and patient comfort throughout treatments. This has resulted in excellent product acceptance as compared to manual compression procedures previously employed in the industry. Furthermore, product approvals, as well as a growth in the number of registrations for novel devices by industry participants seeking a competitive advantage, would improve the market value.

The benefit of active vascular closure devices in shortening time to ambulation and haemostasis commanded more than 58 percent of revenue share in 2020. The active vascular closure device employs a variety of ways for direct closure of the artery entry site, including the use of collagen or suture-based materials. Increasing product availability to a bigger population opens up revenue generation opportunities for the segment. Collagen plug devices such as Angio-seal and Mynx, as well as ExoSeal and Starclose devices, are examples of these devices. As a result, more product releases by market participants will benefit segment growth.

In 2020, hospitals accounted for more than 59 percent of the vascular closure device market. Patient choice for hospitals will be driven by the widespread use of modern gadgets that provide improved cardiac care. The increasing number of heart stroke admissions, the demand for catheterization and angiography procedures, and the availability of highly skilled specialists all drive the demand for closure devices in these facilities. As a result, patient demand for a well-equipped emergency cardiac department will drive segment revenue in the near future.

Vascular Closure Devices Market Key Players

The prominent players in the vascular closure devices market Merit Medical Systems, Inc., Abbott Vascular, Biotronik GMBH & CO.KG, COOK Medtronic, Boston Scientific Corporation, C. R. Bard, Inc., ESSENTIAL MEDICAL, Inc., Cardinal Health, W L. Gore & Associates , ST. JUDE MEDICAL, TZ Medical, Inc., Cardival Medical, Inc., Scion BioMedical.

Who Should Buy? Or Key stakeholders

Investors
Environment, Health and Safety Professionals
Research Organizations
Medical industry
Original Equipment Manufacturer
Regulatory Authorities
Others

Key Takeaways

The global vascular closure devices market is expected to grow at more than 7% CAGR.
Based on type, the market for vascular closure devices is dominated by passive approximators.
Based on procedure, the interventional radiology segment is expected to grow the most.
Hospitals accounted for more than 59 percent of the vascular closure device market.
The increasing preference for minimally invasive procedures drives the growth of the vascular closure devices market.

Vascular Closure Devices Market Regional Analysis

The vascular closure devices market is divided into major regions- North America, Europe, South America, Asia Pacific, and middle east & Africa. North America is the largest regional segment in 2021. Growing penetration of electric cars was the primary factor driving product demand. Furthermore, the growing regulatory support for increasing investments is projected to have a favorable impact on growth.

North America: includes the US, Canada, Mexico
Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
South America: includes Brazil, Argentina and Rest of South America
Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA

The country’s well-established healthcare infrastructure, the growing incidence of cardiovascular illnesses coupled with an increase in catheterization-related procedures, and the rise in demand for minimally invasive treatments are driving market expansion in the region. North America led the global market for vascular closure devices, followed by Europe. The growing prevalence of cardiovascular diseases, the growing trend of one-day surgeries for vascular procedures, increased research and clinical trials for vascular closure devices in the US, the increasing number of cardiac arrest cases, and the long waiting periods for cardiac surgeries (which encourage the adoption of minimally invasive procedures) in Canada all contribute to the large share of the North American market.

Key Market Segments: Global vascular closure devices Market

Vascular Closure Devices Market by Type, 2020-2029, (USD Million, Thousand Units)

Passive Approximaters
Active Approximaters
External Homeostatic Devices

Vascular Closure Devices Market by Access, 2020-2029, (USD Million, Thousand Units)

Radial
Femoral

Vascular Closure Devices Market by Procedure, 2020-2029, (USD Million, Thousand Units)

Interventional Cardiology
Interventional Radiology/Vascular Surgery

Vascular Closure Devices Market by Region, 2020-2029, (USD Million, Thousand Units)

North America
Europe
Asia Pacific
South America
Middle East And Africa

Important Countries in All Regions Are Covered (Total Country Profiles 25)

Key Question Answered

What is the current market size of this high-growth market?
What is the overall growth rate?
What are the key growth areas, types, and applications?
Key reasons for the growth
Challenges for growth
What technological developments are happening in this area?

INTRODUCTION
1. MARKET DEFINITION
2. MARKET SEGMENTATION
3. RESEARCH TIMELINES
4. ASSUMPTIONS AND LIMITATIONS
RESEARCH METHODOLOGY
1. DATA MINING
  1. SECONDARY RESEARCH
  2. PRIMARY RESEARCH
  3. SUBJECT-MATTER EXPERTS’ ADVICE
2. QUALITY CHECKS
  1. FINAL REVIEW
3. DATA TRIANGULATION
  1. BOTTOM-UP APPROACH
  2. TOP-DOWN APPROACH
  3. RESEARCH FLOW
4. DATA SOURCES
EXECUTIVE SUMMARY
MARKET OVERVIEW
1. GLOBAL URINALYSIS MARKET OUTLOOK
  1. MARKET DRIVERS
  2. MARKET RESTRAINTS
  3. MARKET OPPORTUNITIES
2. IMPACT OF COVID-19 ON URINALYSIS MARKET
3. PORTER’S FIVE FORCES MODEL
  1. THREAT FROM NEW ENTRANTS
  2. THREAT FROM SUBSTITUTES
  3. BARGAINING POWER OF SUPPLIERS
  4. BARGAINING POWER OF CUSTOMERS
  5. DEGREE OF COMPETITION
4. INDUSTRY VALUE CHAIN ANALYSIS
GLOBAL URINALYSIS MARKET BY TYPE, (USD MILLION)
1. PASSIVE APPROXIMATORS
2. ACTIVE APPROXIMATORS
3. EXTERNAL HOMEOSTATIC DEVICES
GLOBAL URINALYSIS MARKET BY ACCESS, (USD MILLION)
1. RADIAL
2. FEMORAL
GLOBAL URINALYSIS MARKET BY PROCEDURE (USD MILLION) (KILOTONS)
1. INTERVENTIONAL CARDIOLOGY
2. INTERVENTIONAL RADIOLOGY/VASCULAR SURGERY
GLOBAL URINALYSIS MARKET BY REGION
1. NORTH AMERICA
  1. US
  2. CANADA
  3. MEXICO
2. SOUTH AMERICA
  1. BRAZIL
  2. ARGENTINA
  3. COLOMBIA
  4. REST OF SOUTH AMERICA
3. EUROPE
  1. GERMANY
  2. UK
  3. FRANCE
  4. ITALY
  5. SPAIN
  6. RUSSIA
  7. REST OF EUROPE
4. ASIA PACIFIC
  1. INDIA
  2. CHINA
  3. JAPAN
  4. SOUTH KOREA
  5. AUSTRALIA
  6. SOUTH-EAST ASIA
  7. REST OF ASIA PACIFIC
5. MIDDLE EAST AND AFRICA
  1. UAE
  2. SAUDI ARABIA
  3. SOUTH AFRICA
  4. REST OF MIDDLE EAST AND AFRICA

COMPANY PROFILES* (BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)
1. MERIT MEDICAL SYSTEMS, INC.
2. ABBOTT VASCULAR
3. BIOTRONIK GMBH & CO.KG
4. COOK
5. MEDTRONIC
6. BOSTON SCIENTIFIC CORPORATION
7. R. BARD, INC.
8. ESSENTIAL MEDICAL, INC.
9. CARDINAL HEALTH
10. W L. GORE & ASSOCIATES
11. JUDE MEDICAL
12. TZ MEDICAL, INC.
13. CARDIVAL MEDICAL, INC.
14. SCION BIOMEDICAL
15. INFOMED OTHERS *THE COMPANY LIST IS INDICATIVE

LIST OF TABLES

TABLE 1 GLOBAL URINALYSIS MARKET BY TYPE(USD MILLIONS) 2020-2029

TABLE 2 GLOBAL URINALYSIS MARKET BY TYPE(KILOTONS) 2020-2029

TABLE 3 GLOBAL URINALYSIS MARKET BY ACCESS(USD MILLIONS) 2020-2029

TABLE 4 GLOBAL URINALYSIS MARKET BY ACCESS(KILOTONS) 2020-2029

TABLE 5 GLOBAL URINALYSIS MARKET BY PROCEDURE(USD MILLIONS) 2020-2029

TABLE 6 GLOBAL URINALYSIS MARKET BY PROCEDURE(KILOTONS) 2020-2029

TABLE 7 GLOBAL URINALYSIS MARKET BY REGION (USD MILLIONS) 2020-2029

TABLE 8 GLOBAL URINALYSIS MARKET BY REGION (KILOTONS) 2020-2029

TABLE 9 US URINALYSIS MARKET BY TYPE(USD MILLIONS) 2020-2029

TABLE 10 US URINALYSIS MARKET BY TYPE(KILOTONS) 2020-2029

TABLE 11 US URINALYSIS MARKET BY ACCESS(USD MILLIONS) 2020-2029

TABLE 12 US URINALYSIS MARKET BY ACCESS(KILOTONS) 2020-2029

TABLE 13 US URINALYSIS MARKET BY PROCEDURE(USD MILLIONS) 2020-2029

TABLE 14 US URINALYSIS MARKET BY PROCEDURE(KILOTONS) 2020-2029

TABLE 15 CANADA URINALYSIS MARKET BY TYPE(USD MILLIONS) 2020-2029

TABLE 16 CANADA URINALYSIS MARKET BY TYPE(KILOTONS) 2020-2029

TABLE 17 CANADA URINALYSIS MARKET BY ACCESS(USD MILLIONS) 2020-2029

TABLE 18 CANADA URINALYSIS MARKET BY ACCESS(KILOTONS) 2020-2029

TABLE 19 CANADA URINALYSIS MARKET BY PROCEDURE(USD MILLIONS) 2020-2029

TABLE 20 CANADA URINALYSIS MARKET BY PROCEDURE(KILOTONS) 2020-2029

TABLE 21 MEXICO URINALYSIS MARKET BY TYPE(USD MILLIONS) 2020-2029

TABLE 22 MEXICO URINALYSIS MARKET BY TYPE(KILOTONS) 2020-2029

TABLE 23 MEXICO URINALYSIS MARKET BY ACCESS(USD MILLIONS) 2020-2029

TABLE 24 MEXICO URINALYSIS MARKET BY ACCESS(KILOTONS) 2020-2029

TABLE 25 MEXICO URINALYSIS MARKET BY PROCEDURE(USD MILLIONS) 2020-2029

TABLE 26 MEXICO URINALYSIS MARKET BY PROCEDURE(KILOTONS) 2020-2029

TABLE 27 BRAZIL URINALYSIS MARKET BY TYPE(USD MILLIONS) 2020-2029

TABLE 28 BRAZIL URINALYSIS MARKET BY TYPE(KILOTONS) 2020-2029

TABLE 29 BRAZIL URINALYSIS MARKET BY ACCESS(USD MILLIONS) 2020-2029

TABLE 30 BRAZIL URINALYSIS MARKET BY ACCESS(KILOTONS) 2020-2029

TABLE 31 BRAZIL URINALYSIS MARKET BY PROCEDURE(USD MILLIONS) 2020-2029

TABLE 32 BRAZIL URINALYSIS MARKET BY PROCEDURE(KILOTONS) 2020-2029

TABLE 33 ARGENTINA URINALYSIS MARKET BY TYPE(USD MILLIONS) 2020-2029

TABLE 34 ARGENTINA URINALYSIS MARKET BY TYPE(KILOTONS) 2020-2029

TABLE 35 ARGENTINA URINALYSIS MARKET BY ACCESS(USD MILLIONS) 2020-2029

TABLE 36 ARGENTINA URINALYSIS MARKET BY ACCESS(KILOTONS) 2020-2029

TABLE 37 ARGENTINA URINALYSIS MARKET BY PROCEDURE(USD MILLIONS) 2020-2029

TABLE 38 ARGENTINA URINALYSIS MARKET BY PROCEDURE(KILOTONS) 2020-2029

TABLE 39 COLOMBIA URINALYSIS MARKET BY TYPE(USD MILLIONS) 2020-2029

TABLE 40 COLOMBIA URINALYSIS MARKET BY TYPE(KILOTONS) 2020-2029

TABLE 41 COLOMBIA URINALYSIS MARKET BY ACCESS(USD MILLIONS) 2020-2029

TABLE 42 COLOMBIA URINALYSIS MARKET BY ACCESS(KILOTONS) 2020-2029

TABLE 43 COLOMBIA URINALYSIS MARKET BY PROCEDURE(USD MILLIONS) 2020-2029

TABLE 44 COLOMBIA URINALYSIS MARKET BY PROCEDURE(KILOTONS) 2020-2029

TABLE 45 REST OF SOUTH AMERICA URINALYSIS MARKET BY TYPE(USD MILLIONS) 2020-2029

TABLE 46 REST OF SOUTH AMERICA URINALYSIS MARKET BY TYPE(KILOTONS) 2020-2029

TABLE 47 REST OF SOUTH AMERICA URINALYSIS MARKET BY ACCESS(USD MILLIONS) 2020-2029

TABLE 48 REST OF SOUTH AMERICA URINALYSIS MARKET BY ACCESS(KILOTONS) 2020-2029

TABLE 49 REST OF SOUTH AMERICA URINALYSIS MARKET BY PROCEDURE(USD MILLIONS) 2020-2029

TABLE 50 REST OF SOUTH AMERICA URINALYSIS MARKET BY PROCEDURE(KILOTONS) 2020-2029

TABLE 51 INDIA URINALYSIS MARKET BY TYPE(USD MILLIONS) 2020-2029

TABLE 52 INDIA URINALYSIS MARKET BY TYPE(KILOTONS) 2020-2029

TABLE 53 INDIA URINALYSIS MARKET BY ACCESS(USD MILLIONS) 2020-2029

TABLE 54 INDIA URINALYSIS MARKET BY ACCESS(KILOTONS) 2020-2029

TABLE 55 INDIA URINALYSIS MARKET BY PROCEDURE(USD MILLIONS) 2020-2029

TABLE 56 INDIA URINALYSIS MARKET BY END-USER (KILOTONS) 2020-2029

TABLE 57 CHINA URINALYSIS MARKET BY TYPE(USD MILLIONS) 2020-2029

TABLE 58 CHINA URINALYSIS MARKET BY TYPE(KILOTONS) 2020-2029

TABLE 59 CHINA URINALYSIS MARKET BY ACCESS(USD MILLIONS) 2020-2029

TABLE 60 CHINA URINALYSIS MARKET BY ACCESS(KILOTONS) 2020-2029

TABLE 61 CHINA URINALYSIS MARKET BY PROCEDURE(USD MILLIONS) 2020-2029

TABLE 62 CHINA URINALYSIS MARKET BY PROCEDURE(KILOTONS) 2020-2029

TABLE 63 JAPAN URINALYSIS MARKET BY TYPE(USD MILLIONS) 2020-2029

TABLE 64 JAPAN URINALYSIS MARKET BY TYPE(KILOTONS) 2020-2029

TABLE 65 JAPAN URINALYSIS MARKET BY ACCESS(USD MILLIONS) 2020-2029

TABLE 66 JAPAN URINALYSIS MARKET BY ACCESS(KILOTONS) 2020-2029

TABLE 67 JAPAN URINALYSIS MARKET BY PROCEDURE(USD MILLIONS) 2020-2029

TABLE 68 JAPAN URINALYSIS MARKET BY PROCEDURE(KILOTONS) 2020-2029

TABLE 69 SOUTH KOREA URINALYSIS MARKET BY TYPE(USD MILLIONS) 2020-2029

TABLE 70 SOUTH KOREA URINALYSIS MARKET BY TYPE(KILOTONS) 2020-2029

TABLE 71 SOUTH KOREA URINALYSIS MARKET BY ACCESS(USD MILLIONS) 2020-2029

TABLE 72 SOUTH KOREA URINALYSIS MARKET BY ACCESS(KILOTONS) 2020-2029

TABLE 73 SOUTH KOREA M MARKET BY PROCEDURE(USD MILLIONS) 2020-2029

TABLE 74 SOUTH KOREA URINALYSIS MARKET BY PROCEDURE(KILOTONS) 2020-2029

TABLE 75 AUSTRALIA URINALYSIS MARKET BY TYPE(USD MILLIONS) 2020-2029

TABLE 76 AUSTRALIA URINALYSIS MARKET BY TYPE(KILOTONS) 2020-2029

TABLE 77 AUSTRALIA URINALYSIS MARKET BY ACCESS(USD MILLIONS) 2020-2029

TABLE 78 AUSTRALIA URINALYSIS MARKET BY ACCESS(KILOTONS) 2020-2029

TABLE 79 AUSTRALIA URINALYSIS MARKET BY PROCEDURE(USD MILLIONS) 2020-2029

TABLE 80 AUSTRALIA URINALYSIS MARKET BY PROCEDURE(KILOTONS) 2020-2029

TABLE 81 SOUTH-EAST ASIA URINALYSIS MARKET BY TYPE(USD MILLIONS) 2020-2029

TABLE 82 SOUTH-EAST ASIA URINALYSIS MARKET BY TYPE(KILOTONS) 2020-2029

TABLE 83 SOUTH-EAST ASIA URINALYSIS MARKET BY ACCESS(USD MILLIONS) 2020-2029

TABLE 84 SOUTH-EAST ASIA URINALYSIS MARKET BY ACCESS(KILOTONS) 2020-2029

TABLE 85 SOUTH-EAST ASIA URINALYSIS MARKET BY PROCEDURE(USD MILLIONS) 2020-2029

TABLE 86 SOUTH-EAST ASIA URINALYSIS MARKET BY PROCEDURE(KILOTONS) 2020-2029

TABLE 87 REST OF ASIA PACIFIC URINALYSIS MARKET BY TYPE(USD MILLIONS) 2020-2029

TABLE 88 REST OF ASIA PACIFIC URINALYSIS MARKET BY TYPE(KILOTONS) 2020-2029

TABLE 89 REST OF ASIA PACIFIC URINALYSIS MARKET BY ACCESS(USD MILLIONS) 2020-2029

TABLE 90 REST OF ASIA PACIFIC URINALYSIS MARKET BY ACCESS(KILOTONS) 2020-2029

TABLE 91 REST OF ASIA PACIFIC URINALYSIS MARKET BY PROCEDURE(USD MILLIONS) 2020-2029

TABLE 92 REST OF ASIA PACIFIC URINALYSIS MARKET BY PROCEDURE(KILOTONS) 2020-2029

TABLE 93 GERMANY URINALYSIS MARKET BY TYPE(USD MILLIONS) 2020-2029

TABLE 94 GERMANY URINALYSIS MARKET BY TYPE(KILOTONS) 2020-2029

TABLE 95 GERMANY URINALYSIS MARKET BY ACCESS(USD MILLIONS) 2020-2029

TABLE 96 GERMANY URINALYSIS MARKET BY ACCESS(KILOTONS) 2020-2029

TABLE 97 GERMANY URINALYSIS MARKET BY PROCEDURE(USD MILLIONS) 2020-2029

TABLE 98 GERMANY URINALYSIS MARKET BY PROCEDURE(KILOTONS) 2020-2029

TABLE 99 UK URINALYSIS MARKET BY TYPE(USD MILLIONS) 2020-2029

TABLE 100 UK URINALYSIS MARKET BY TYPE(KILOTONS) 2020-2029

TABLE 101 UK URINALYSIS MARKET BY ACCESS(USD MILLIONS) 2020-2029

TABLE 102 UK URINALYSIS MARKET BY ACCESS(KILOTONS) 2020-2029

TABLE 103 UK URINALYSIS MARKET BY PROCEDURE(USD MILLIONS) 2020-2029

TABLE 104 UK URINALYSIS MARKET BY PROCEDURE(KILOTONS) 2020-2029

TABLE 105 FRANCE URINALYSIS MARKET BY TYPE(USD MILLIONS) 2020-2029

TABLE 106 FRANCE URINALYSIS MARKET BY TYPE(KILOTONS) 2020-2029

TABLE 107 FRANCE URINALYSIS MARKET BY ACCESS(USD MILLIONS) 2020-2029

TABLE 108 FRANCE URINALYSIS MARKET BY ACCESS(KILOTONS) 2020-2029

TABLE 109 FRANCE URINALYSIS MARKET BY PROCEDURE(USD MILLIONS) 2020-2029

TABLE 110 FRANCE URINALYSIS MARKET BY PROCEDURE(KILOTONS) 2020-2029

TABLE 111 ITALY URINALYSIS MARKET BY TYPE(USD MILLIONS) 2020-2029

TABLE 112 ITALY URINALYSIS MARKET BY TYPE(KILOTONS) 2020-2029

TABLE 113 ITALY URINALYSIS MARKET BY ACCESS(USD MILLIONS) 2020-2029

TABLE 114 ITALY URINALYSIS MARKET BY ACCESS(KILOTONS) 2020-2029

TABLE 115 ITALY URINALYSIS MARKET BY PROCEDURE(USD MILLIONS) 2020-2029

TABLE 116 ITALY URINALYSIS MARKET BY PROCEDURE(KILOTONS) 2020-2029

TABLE 117 SPAIN URINALYSIS MARKET BY TYPE(USD MILLIONS) 2020-2029

TABLE 118 SPAIN URINALYSIS MARKET BY TYPE(KILOTONS) 2020-2029

TABLE 119 SPAIN URINALYSIS MARKET BY ACCESS(USD MILLIONS) 2020-2029

TABLE 120 SPAIN URINALYSIS MARKET BY ACCESS(KILOTONS) 2020-2029

TABLE 121 SPAIN URINALYSIS MARKET BY PROCEDURE(USD MILLIONS) 2020-2029

TABLE 122 SPAIN URINALYSIS MARKET BY PROCEDURE(KILOTONS) 2020-2029

TABLE 123 RUSSIA URINALYSIS MARKET BY TYPE(USD MILLIONS) 2020-2029

TABLE 124 RUSSIA URINALYSIS MARKET BY TYPE(KILOTONS) 2020-2029

TABLE 125 RUSSIA URINALYSIS MARKET BY ACCESS(USD MILLIONS) 2020-2029

TABLE 126 RUSSIA URINALYSIS MARKET BY ACCESS(KILOTONS) 2020-2029

TABLE 127 RUSSIA URINALYSIS MARKET BY PROCEDURE(USD MILLIONS) 2020-2029

TABLE 128 RUSSIA URINALYSIS MARKET BY PROCEDURE(KILOTONS) 2020-2029

TABLE 129 REST OF EUROPE URINALYSIS MARKET BY TYPE(USD MILLIONS) 2020-2029

TABLE 130 REST OF EUROPE URINALYSIS MARKET BY TYPE(KILOTONS) 2020-2029

TABLE 131 REST OF EUROPE URINALYSIS MARKET BY ACCESS(USD MILLIONS) 2020-2029

TABLE 132 REST OF EUROPE URINALYSIS MARKET BY ACCESS(KILOTONS) 2020-2029

TABLE 133 REST OF EUROPE URINALYSIS MARKET BY PROCEDURE(USD MILLIONS) 2020-2029

TABLE 134 REST OF EUROPE URINALYSIS MARKET BY PROCEDURE(KILOTONS) 2020-2029

TABLE 135 UAE URINALYSIS MARKET BY TYPE(USD MILLIONS) 2020-2029

TABLE 136 UAE URINALYSIS MARKET BY TYPE(KILOTONS) 2020-2029

TABLE 137 UAE URINALYSIS MARKET BY ACCESS(USD MILLIONS) 2020-2029

TABLE 138 UAE URINALYSIS MARKET BY ACCESS(KILOTONS) 2020-2029

TABLE 139 UAE URINALYSIS MARKET BY PROCEDURE(USD MILLIONS) 2020-2029

TABLE 140 UAE URINALYSIS MARKET BY PROCEDURE(KILOTONS) 2020-2029

TABLE 141 SAUDI ARABIA URINALYSIS MARKET BY TYPE(USD MILLIONS) 2020-2029

TABLE 142 SAUDI ARABIA URINALYSIS MARKET BY TYPE(KILOTONS) 2020-2029

TABLE 143 SAUDI ARABIA URINALYSIS MARKET BY ACCESS(USD MILLIONS) 2020-2029

TABLE 144 SAUDI ARABIA URINALYSIS MARKET BY ACCESS(KILOTONS) 2020-2029

TABLE 145 SAUDI ARABIA URINALYSIS MARKET BY PROCEDURE(USD MILLIONS) 2020-2029

TABLE 146 SAUDI ARABIA URINALYSIS MARKET BY PROCEDURE(KILOTONS) 2020-2029

TABLE 147 SOUTH AFRICA URINALYSIS MARKET BY TYPE(USD MILLIONS) 2020-2029

TABLE 148 SOUTH AFRICA URINALYSIS MARKET BY TYPE(KILOTONS) 2020-2029

TABLE 149 SOUTH AFRICA URINALYSIS MARKET BY ACCESS(USD MILLIONS) 2020-2029

TABLE 150 SOUTH AFRICA URINALYSIS MARKET BY ACCESS(KILOTONS) 2020-2029

TABLE 151 SOUTH AFRICA URINALYSIS MARKET BY PROCEDURE(USD MILLIONS) 2020-2029

TABLE 152 SOUTH AFRICA URINALYSIS MARKET BY PROCEDURE(KILOTONS) 2020-2029

TABLE 153 REST OF MIDDLE EAST AND AFRICA URINALYSIS MARKET BY TYPE(USD MILLIONS) 2020-2029

TABLE 154 REST OF MIDDLE EAST AND AFRICA URINALYSIS MARKET BY TYPE(KILOTONS) 2020-2029

TABLE 155 REST OF MIDDLE EAST AND AFRICA URINALYSIS MARKET BY ACCESS(USD MILLIONS) 2020-2029

TABLE 156 REST OF MIDDLE EAST AND AFRICA URINALYSIS MARKET BY ACCESS(KILOTONS) 2020-2029

TABLE 157 REST OF MIDDLE EAST AND AFRICA URINALYSIS MARKET BY PROCEDURE(USD MILLIONS) 2020-2029

TABLE 158 REST OF MIDDLE EAST AND AFRICA URINALYSIS MARKET BY PROCEDURE(KILOTONS) 2020-2029

LIST OF FIGURES

FIGURE 1 MARKET DYNAMICS

FIGURE 2 MARKET SEGMENTATION

FIGURE 3 REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4 DATA TRIANGULATION

FIGURE 5 BOTTOM-UP APPROACH

FIGURE 6 TOP-DOWN APPROACH

FIGURE 7 RESEARCH FLOW

FIGURE 8 GLOBAL URINALYSIS MARKET BY VEHICLE TYPE, USD MILLION, 2020-2029

FIGURE 9 GLOBAL URINALYSIS MARKET BY APPLICATION, USD MILLION, 2020-2029

FIGURE 10 GLOBAL URINALYSIS MARKET BY APPLICATION, USD MILLION, 2020-2029

FIGURE 11 GLOBAL URINALYSIS MARKET BY REGION, USD MILLION, 2020-2029

FIGURE 12 PORTER’S FIVE FORCES MODEL

FIGURE 13 NORTH AMERICA URINALYSIS MARKET SNAPSHOT

FIGURE 14 EUROPE URINALYSIS MARKET SNAPSHOT

FIGURE 15 ASIA PACIFIC URINALYSIS MARKET SNAPSHOT

FIGURE 16 SOUTH AMERICA URINALYSIS MARKET SNAPSHOT

FIGURE 17 MIDDLE EAST & AFRICA URINALYSIS MARKET SNAPSHOT

FIGURE 18 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT

FIGURE 19 ABBOTT VASCULAR: COMPANY SNAPSHOT

FIGURE 20 BIOTRONIK GMBH & CO.KG: COMPANY SNAPSHOT

FIGURE 21 COOK: COMPANY SNAPSHOT

FIGURE 22 MEDTRONIC: COMPANY SNAPSHOT

FIGURE 23 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT

FIGURE 24 C. R. BARD, INC.: COMPANY SNAPSHOT

FIGURE 25 ESSENTIAL MEDICAL, INC.: COMPANY SNAPSHOT

FIGURE 26 CARDINAL HEALTH: COMPANY SNAPSHOT

FIGURE 27 W L. GORE & ASSOCIATES: COMPANY SNAPSHOT

FIGURE 28 ST. JUDE MEDICAL: COMPANY SNAPSHOT

FIGURE 29 TZ MEDICAL, INC.: COMPANY SNAPSHOT

FIGURE 30 CARDIVAL MEDICAL, INC.: COMPANY SNAPSHOT

In-Depth Database

Our Report’s database covers almost all topics of all regions over the Globe.

Recognised Publishing Sources

Tie ups with top publishers around the globe.

Customer Support

Complete pre and post sales
support.

Safe & Secure

Complete secure payment
process.

INTERESTED IN THIS RESEARCH?

REPORT OUTLOOK

SCOPE OF THE REPORT

Vascular Closure Devices Market Overview

Vascular Closure Devices Market Segment Analysis

Vascular Closure Devices Market Key Players

Who Should Buy? Or Key stakeholders

Key Takeaways

Vascular Closure Devices Market Regional Analysis

Key Market Segments: Global vascular closure devices Market

Key Question Answered

Table of Content

LIST OF TABLES

LIST OF FIGURES

DOWNLOAD FREE SAMPLE REPORT

Inquire for Discount

In-Depth Database

Recognised Publishing Sources

Customer Support

Safe & Secure

6 Elmore Road, Luton, Bedfordshire LU20QB, UK

Plot No. 39, SR, 10-16, NDA Pashan Rd, Bavdhan, Pune, Maharashtra 411021

Subscribe our newsletter

INTERESTED IN THIS RESEARCH?

REPORT OUTLOOK

SCOPE OF THE REPORT

Vascular Closure Devices Market Overview

Vascular Closure Devices Market Segment Analysis

Vascular Closure Devices Market Key Players

Who Should Buy? Or Key stakeholders

Key Takeaways

Vascular Closure Devices Market Regional Analysis

Key Market Segments: Global vascular closure devices Market

Key Question Answered

Table of Content

LIST OF TABLES

LIST OF FIGURES

Related Reports

DOWNLOAD FREE SAMPLE REPORT

Inquire for Discount

In-Depth Database

Recognised Publishing Sources

Customer Support

Safe & Secure